Putative role of immune reactions in the mechanism of tardive dyskinesia.
AIMS
Cytokines
Drug-induced movement disorders
Habenula
Neuroinflammation
Oxidative stress
Tardive dyskinesia
Journal
Brain, behavior, & immunity - health
ISSN: 2666-3546
Titre abrégé: Brain Behav Immun Health
Pays: United States
ID NLM: 101759062
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
06
09
2023
accepted:
13
09
2023
medline:
9
10
2023
pubmed:
9
10
2023
entrez:
9
10
2023
Statut:
epublish
Résumé
The term extrapyramidal disorders is most often used for conditions such as Parkinson's disease or Huntington's disease, but also refers to a group of extrapyramidal side effects of antipsychotics (EPS), such as tardive dyskinesia (TD). After a brief description of some clinical features of TD, this article summarizes the relatively scarce results of research on a possible link between mainly cytokine levels and TD. This data was found by systematically searching Pubmed and Embase. The limitations of these types of studies are a major obstacle to interpretation. After describing relevant aspects of the neuroinflammatory response and the neuroanatomical backgrounds of EPS, a new hypothesis for the origin of TD is presented with emphasis on dysfunctions in the striosomal compartment of the striatum and the dorsal diencephalic connection system (DDCS). It is postulated that (partly immunologically-induced) increase in oxidative stress and the dopamine-dependent immune response in classic TD proceed primarily via the DDCS, which itself is activated from evolutionarily older parts of the forebrain. Neuroinflammatory responses in the choroid plexus of the third ventricle may contribute due to its proximity to the habenula. It is concluded that direct evidence for a possible role of inflammatory processes in the mechanism of TD is still lacking because research on this is still too much of a niche, but there are indications that warrant further investigation.
Identifiants
pubmed: 37810262
doi: 10.1016/j.bbih.2023.100687
pii: S2666-3546(23)00101-1
pmc: PMC10550815
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100687Informations de copyright
© 2023 The Author.
Déclaration de conflit d'intérêts
None.
Références
Neurotox Res. 2011 Oct;20(3):215-25
pubmed: 21076901
Neurochem Res. 2016 Sep;41(9):2481-9
pubmed: 27230882
Schizophr Res. 2015 Mar;162(1-3):261-8
pubmed: 25600548
J Neuroimmune Pharmacol. 2017 Dec;12(4):602-623
pubmed: 28578466
J Geriatr Psychiatry Neurol. 1990 Oct-Dec;3(4):208-11
pubmed: 1981469
Int J Mol Sci. 2022 Apr 01;23(7):
pubmed: 35409300
Handb Clin Neurol. 2017;146:21-32
pubmed: 29110772
Behav Brain Res. 2017 Jun 30;329:6-11
pubmed: 28442354
Mol Neurobiol. 2016 Mar;53(2):1181-1194
pubmed: 25598354
Biomedicines. 2022 Jan 21;10(2):
pubmed: 35203434
Psychiatry Investig. 2020 Oct;17(10):1031-1036
pubmed: 33059393
Rev Psiquiatr Salud Ment (Engl Ed). 2018 Apr - Jun;11(2):115-124
pubmed: 28993125
Brain Sci. 2017 Jun 07;7(6):
pubmed: 28590448
J Neuropsychiatry Clin Neurosci. 1995 Spring;7(2):223-9
pubmed: 7626967
BMC Psychiatry. 2013 May 28;13:152
pubmed: 23714238
Front Neurosci. 2015 Oct 21;9:372
pubmed: 26539073
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Life (Basel). 2022 Nov 25;12(12):
pubmed: 36556337
J Psychiatr Res. 2021 Oct;142:290-298
pubmed: 34411812
Arch Gen Psychiatry. 1982 Apr;39(4):473-81
pubmed: 6121548
J Neurol Sci. 2018 Jun 15;389:17-20
pubmed: 29433811
Annu Rev Physiol. 2017 Feb 10;79:619-643
pubmed: 27959620
Prog Neurobiol. 2019 Aug;179:101614
pubmed: 31075285
J Neurol Sci. 2018 Jun 15;389:21-27
pubmed: 29439776
Hum Psychopharmacol. 2010 Jan;25(1):84-91
pubmed: 20041472
Int J Geriatr Psychiatry. 2016 Jul;31(7):683-93
pubmed: 26679687
Ugeskr Laeger. 2019 Apr 22;181(17):
pubmed: 31036138
Curr Opin Psychiatry. 2015 May;28(3):201-6
pubmed: 25768084
CNS Drugs. 2003;17(1):47-62
pubmed: 12467492
Schizophr Bull. 2020 Apr 10;46(3):722-731
pubmed: 31603232
Neuron. 2013 Jan 9;77(1):10-8
pubmed: 23312512
Chest. 1994 Jun;105(6):1826-32
pubmed: 7911419
Acta Neuropsychiatr. 2018 Feb;30(1):29-42
pubmed: 28473012
Schizophr Res. 2023 Feb;252:33-35
pubmed: 36621324
J Clin Psychopharmacol. 2007 Oct;27(5):423-30
pubmed: 17873670
Ther Adv Psychopharmacol. 2022 Oct 21;12:20451253221117313
pubmed: 36312846
Arch Toxicol. 2021 Mar;95(3):767-789
pubmed: 33398419
Trends Neurosci. 2021 Nov;44(11):864-875
pubmed: 34312005
Annu Rev Neurosci. 2009;32:127-47
pubmed: 19400717
ACS Chem Neurosci. 2017 Feb 15;8(2):235-242
pubmed: 27977131
Front Cell Neurosci. 2021 Feb 10;15:628010
pubmed: 33642998
Schizophr Res. 2005 Dec 1;80(1):33-43
pubmed: 16171976
Front Psychiatry. 2020 Nov 25;11:602121
pubmed: 33324265
Pharmacol Rev. 2018 Apr;70(2):278-314
pubmed: 29496890
Mov Disord. 2004 Aug;19(8):892-6
pubmed: 15300653
Int J Neuropsychopharmacol. 2000 Dec;3(4):285-296
pubmed: 11343606
CNS Spectr. 2019 Apr;24(2):233-238
pubmed: 29091022
Pharmacol Biochem Behav. 2013 Oct;111:17-23
pubmed: 23948071
Pharmacogenomics. 2019 Nov;20(17):1199-1223
pubmed: 31686592
Acta Psychiatr Scand. 1994 Nov;90(5):311-5
pubmed: 7872033
J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):917-29
pubmed: 24464858
Int Immunopharmacol. 2019 Nov;76:105908
pubmed: 31622861
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11318-11323
pubmed: 27647894
Neurochem Res. 2022 Dec;47(12):3556-3564
pubmed: 36222957
Acta Neuropsychiatr. 2022 Oct;34(5):229-239
pubmed: 35587050
Schizophr Bull. 2010 Jul;36(4):723-31
pubmed: 18990712
Neural Regen Res. 2020 Dec;15(12):2173-2185
pubmed: 32594028
Hum Psychopharmacol. 2017 Jan;32(1):
pubmed: 28120489
Ann Neurosci. 2014 Jul;21(3):112-4
pubmed: 25206077
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1473-8
pubmed: 18554768
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:259-64
pubmed: 24995685
Neuron. 2020 Nov 25;108(4):608-622
pubmed: 32898475
J Clin Psychiatry. 2017 Mar;78(3):e264-e278
pubmed: 28146614
Brain Behav Immun. 2015 Nov;50:1-13
pubmed: 26116435
Nat Rev Immunol. 2016 Jan;16(1):22-34
pubmed: 26711676
Mol Biol Rep. 2022 Mar;49(3):1917-1923
pubmed: 34854012
Acta Psychiatr Scand. 1986 May;73(5):506-10
pubmed: 2875609
Dis Markers. 2022 Mar 8;2022:1767989
pubmed: 35299866
Neurotox Res. 2018 Oct;34(3):375-387
pubmed: 29629512
Curr Psychiatry Rep. 2017 Oct 30;19(12):97
pubmed: 29086118
Molecules. 2023 Aug 09;28(16):
pubmed: 37630232
J Neural Transm Suppl. 2009;(73):49-58
pubmed: 20411767
Brain Behav Immun. 2018 Nov;74:241-251
pubmed: 30217539
Neuropharmacology. 2021 Oct 1;197:108728
pubmed: 34331960
Psychiatry Res. 2012 Jul 30;198(2):329-31
pubmed: 22417931
Neurochem Res. 2013 Feb;38(2):433-42
pubmed: 23212700
Acta Psychiatr Scand. 2022 Jul;146(1):6-20
pubmed: 35202480
J Clin Psychiatry. 2011 Mar;72(3):295-303
pubmed: 20816031
Nervenarzt. 2019 May;90(5):472-484
pubmed: 30341543
Mov Disord. 2006 May;21(5):589-98
pubmed: 16532448
CNS Spectr. 2013 Feb;18(1):15-20
pubmed: 23593652
J Neurosci. 2001 Sep 15;21(18):7247-60
pubmed: 11549735
Asian J Psychiatr. 2018 Feb;32:92-98
pubmed: 29222987
J Comp Neurol. 1988 Mar 22;269(4):506-22
pubmed: 2453535
Eur J Pharmacol. 2016 Jan 15;771:229-35
pubmed: 26712377
J Clin Psychopharmacol. 2008 Oct;28(5):536-9
pubmed: 18794649
Front Immunol. 2018 Apr 13;9:698
pubmed: 29706957
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30;33(3):475-81
pubmed: 19439249
Neurosci Res. 2021 Jun;167:17-29
pubmed: 33316304
Eur J Pharmacol. 2008 Aug 20;590(1-3):241-5
pubmed: 18590723
Curr Top Behav Neurosci. 2020;44:9-34
pubmed: 30739307
J Psychopharmacol. 2012 May;26(5 Suppl):33-41
pubmed: 22472311
Curr Biol. 2019 Jan 7;29(1):51-61.e5
pubmed: 30554903
Sci China Life Sci. 2021 Jun;64(6):911-925
pubmed: 33068286
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110367
pubmed: 34048863
Curr Opin Psychiatry. 2008 Mar;21(2):151-6
pubmed: 18332662
Nature. 2016 Nov 10;539(7628):289-293
pubmed: 27652894
J Neurol Sci. 2018 Jun 15;389:35-42
pubmed: 29506749
PLoS One. 2013 Aug 07;8(8):e70963
pubmed: 23951054
Front Aging Neurosci. 2022 Aug 11;14:965169
pubmed: 36034148
World Psychiatry. 2018 Oct;17(3):330-340
pubmed: 30192088
Curr Med Sci. 2020 Jun;40(3):391-400
pubmed: 32681244
Int Rev Neurobiol. 2011;98:187-210
pubmed: 21907088
J Immunol. 1990 Apr 15;144(8):2999-3007
pubmed: 2109008
Neurotox Res. 2022 Dec;40(6):2089-2102
pubmed: 36385437
J Chem Neuroanat. 2000 Dec;20(3-4):207-13
pubmed: 11207419
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):106-10
pubmed: 22227290
Can J Psychiatry. 2005 Aug;50(9):541-7
pubmed: 16262110
Br J Psychiatry. 2003 Jul;183:45-9
pubmed: 12835243
J Clin Psychiatry. 2000;61 Suppl 4:10-4
pubmed: 10739325
CNS Spectr. 2022 Oct 24;:4-14
pubmed: 36278439
Am J Psychiatry. 2019 Jul 1;176(7):564-572
pubmed: 31164007
Neuropathol Appl Neurobiol. 2013 Feb;39(1):3-18
pubmed: 23252647
J Neurosci. 1995 Sep;15(9):5999-6013
pubmed: 7666184
Psychol Med. 2009 Jul;39(7):1065-76
pubmed: 19000340
Front Cell Neurosci. 2020 Jul 29;14:209
pubmed: 32848613
Science. 2005 May 27;308(5726):1314-8
pubmed: 15831717
Tremor Other Hyperkinet Mov (N Y). 2013 Jul 12;3:
pubmed: 23858394
J Psychopharmacol. 2018 Dec;32(12):1277-1285
pubmed: 30255719
J Psychopharmacol. 2021 Jan;35(1):3-14
pubmed: 32900259